HUTCHMED (China) Limited American Depositary Shares

HCM XNAS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

1.9B

Short interest (Jul 15)

0.1%

Net Short (Jul 27 ): 0.0%

Borrow Fee

8.73%

↑ 13.7%

Available Shares

60K

↑ 33.1%

Price Chart

Company Overview

HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.

Company Info

Exchange: NASDAQ

CIK: 0001648257

Asset Type: ADRC

Market Data

Market Cap: $1,893,173,507

Employees: 1,796

Status: Active

Short Interest

Current Borrow Fee 8.73%

Range: 8.07% - 8.92%

Available Shares 60K

Range: 35K - 65K

Recent Changes

Fee Change: ↑ 7.7%

Available Change: ↓ 11.5%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime